StonvexLoading…
StonvexStonvexStonvexCore line items from AVTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.58B | $6.55B | $4.89B | $3.26B |
Operating Income | $99.50M | $-246.20M | $-372.60M | $276.20M |
Net Income | $43.30M | $-530.20M | $-582.60M | $129.20M |
EPS (Diluted) | $0.06 | $-0.78 | $-0.86 | $0.19 |
Total Assets | $11.66B | $11.79B | $11.68B | $12.78B |
Total Liabilities | $6.07B | $6.23B | $6.11B | $6.49B |
Cash & Equivalents | $279.30M | $365.40M | $251.90M | $449.40M |
Free Cash Flow OCF − CapEx | $25.20M | $495.00M | $377.80M | $206.10M |
Shares Outstanding | 682.90M | 682.00M | 681.90M | 681.60M |